Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Matthew D. Galsky, José Ángel Arranz Arija, Aristotelis Bamias, Ian D. Davis, Maria De Santis, Eiji Kikuchi, Xavier Garcia-del-Muro, Ugo De Giorgi, Marina Mencinger, Kouji Izumi, Stefano Panni, Mahmut Gumus, Mustafa Özgüroğlu, Arash Rezazadeh Kalebasty, Se Hoon Park, Boris Alekseev, Fabio A. Schutz, Jian Ri Li, Dingwei Ye, Nicholas J. VogelzangSandrine Bernhard, Darren Tayama, Sanjeev Mariathasan, Almut Mecke, Ann Christine Thåström, Enrique Grande, for the IMvigor130 Study Group

Research output: Contribution to journalArticleResearchpeer-review

543 Citations (Scopus)

Search results